by Baht 10 .97 million (mostly interest paid on loans from directors and financial institutions) 3. Net profit attributable to parent companies for the three months as of August 31, 2017, divided to
% 4,552 59% Total Revenues 494,213 473,402 4% 498,549 -1% Profit / (Loss) before interest and taxation (44,109) (4,437) 894% 3,077 -1,534% Margin -9% -1% 1% Profit / (Loss) for the period (84,511) (47,544
% Cost of sales (290.46 ) (600.93 ) 310.47 (51.66%) (98.17%) (84.80%) GROSS PROFIT 5.42 107.69 (102.27 ) (94.96%) 1.83% 15.20% Distribution costs (26.13 ) (35.11 ) (8.98 ) 25.58% (8.83%) (4.95
% 100.00% Cost of sales (290.46 ) (600.93 ) 310.47 (51.66%) (98.17%) (84.80%) GROSS PROFIT 5.42 107.69 (102.27 ) (94.96%) 1.83% 15.20% Distribution costs (26.13 ) (35.11 ) (8.98 ) 25.58% (8.83%) (4.95
140.96 million along with income from sales to existing customers. 2. Cost of sales and gross profit บริษัท ดโีอด ีไบโอเทค จ ำกดั (มหำชน) 111 หมู่ที่ 2 ต ำบลท่ำจีน อ ำเภอเมืองสมุทรสำคร จังหวดัสมุทรสำคร
Operating Results of the Company in Q3/2020 Q3/18 Q3/20 (THB million) YoY Operating Revenue 219 179 (18%) Gross Profit 137 105 (23%) EBITDA 58 57 (2%) Net Profit for the Company 13 12 (8%) Gross profit margin
expenses of existing outlets such as decreasing personnel expenses with increasing productivity, installation of solar rooftop. 4. Net profit (loss) and net profit (loss) margin For Y2019 net profits was
consolidated net profit of THB 5,983 mn, an increase of 155.4% from the same period of the previous year (YoY). Total revenue stood at THB 11,198 mn, an increase of 53.0% YoY. Excluding a non-recurring item
existing branches and new branches and also increasing in back office expenses. EBITDA profits from the performance in 3Q 2018 compare to in 3Q 2017, the Company EBITDA decreased from 12.9 percent to 12.8
and rendering services 420.82 435.52 14.70 3.49% Cost of rendering hotel services 29.75 23.58 -6.17 -20.75% Total cost 450.57 459.10 8.53 1.89% Gross profit 266.79 348.59 81.80 30.66% Other Income 2.53